Analysis of cerebrospinal fluid soluble interleukin-2 receptor α as a biomarker for autoimmune glial fibrillary acidic protein astrocytopathy
and CSF sIL-2R levels decreased following immunotherapy alongside clinical improvements. These findings suggest that CSF sIL-2R may complement existing biomarkers by supporting the identification of GFAP-A among patients with suspected AE after exclusion of mimics and by providing adjunctive information on treatment-responsive immune activity in GFAP-A.
Authors
- Kotaro Haruna (ORCID: https://orcid.org/0000-0002-8718-0117)
- Hajime Yoshimura (ORCID: https://orcid.org/0000-0002-3523-366X)
- Michi Kawamoto (ORCID: https://orcid.org/0000-0002-5760-4935)
- Junko Ishii
Institutions
- Tokyo Metropolitan Institute of Gerontology (JP)
- Kobe City Medical Center General Hospital (JP)
Publication Details
- Journal
- Immunological Medicine
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1080/25785826.2026.2764548
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00